徵求109年度整合性醫藥衛生科技研究計畫

國家衛生研究院為整合國內醫藥衛生相關研究工作及成果,提升我國醫藥衛生研究水準,即日起公開徵求109年度整合性醫藥衛生科技研究計畫,徵求之研究重點強調問題及任務導向,並希冀能與本院院內研究相輔相成,以有效解決國人重要醫藥衛生問題。

整合性醫藥衛生科技研究計畫

※徵求計畫類型
  1. 台灣醫衛重要主題研究計畫(Thematic Research Grant for Important Health Issues of Taiwan / TRG)
  2. 自109年度起新增一項計畫類型:「台灣醫衛重要主題研究計畫(TRG)」,本計畫類型為統合型計畫,應至少含三個子計畫,最多則以五個子計畫為原則。主要針對國人健康需求及可能面臨之疾病威脅或重大公衛議題,期在有限資源下加速研究成果轉譯應用以解決問題,並產生具體社會及經濟效益為目標,由本院主導、聚焦特定主題,以二年徵求一次為原則。

  3. 個人型計畫:
    (1) 創新研究計畫(Innovative Research Grant / IRG)
    (2) 研究發展獎助計畫(Career Development Grant / CDG)

※研究重點

請詳閱各計畫類型之研究重點,選擇其中符合之項目撰寫計畫書。若未符合研究重點之申請案,恕不受理。

1. 台灣醫衛重要主題研究計畫(TRG)

本次徵求重點以目前對健保支出負擔沈重之腎病變與糖尿病為主軸,且聚焦於急性腎損傷未知原因慢性腎臟病及無法解決的糖尿病所引起之慢性併發症。各研究重點內容詳列如下:

(1) Mechanism and Prevention for Chronic Kidney Disease
Objective:
  • NHRI is committed to facilitating the translation research to reduce burdens caused by end-stage renal disease (ESRD). Therefore, NHRI is soliciting study proposals for a better ESRD prevention strategy.
  • Background:
  • The prevalence and incidence of dialysis in Taiwan have been on the top of the world for more than a decade. Although several government-sponsored healthcare programs such as the diabetes pay-for-performance program, the early CKD program, and the pre-ESRD program have been effectively implemented for many years, the societal impacts incurred by ESRD have not been alleviated. Thus, a new approach is needed to solve this adverse health outcome.
  • Research Priority:
  • Study outcomes should be focused on two emerging issues related to chronic kidney disease: acute kidney injury (AKI) and chronic kidney disease of unknown etiology (CKDu).
  • The applicants are encouraged to adopt a multidisciplinary approach for this research, including (not limited to) recent developments in genetics, immunology, cell biology, biomarker profiling, therapeutic options, diagnosis tools, prediction models, epidemiological analysis, climate change, environmental factors, and/or artificial intelligence application.
  • The scope of this call should include at least 3 interrelated and integrated sub-projects to link a major pathway or target for the investigated outcomes.
  • Research priority of this project is to elucidate causal association in development of end-stage renal disease and/or to identify therapeutic interventions for preventing or reducing the development of dialysis in Taiwan.

  • (2) Mechanism and Prevention for Diabetic Complications
    Objective:
  • NHRI is committed to facilitating the translation research to reduce impacts caused by diabetic complications. Therefore, NHRI is soliciting study proposals to tackle diabetic micro- and/or macrovascular complications.
  • Background:
  • Diabetes-related cardiovascular diseases have been significantly reduced in the USA during the last decade; however, the incidence and prevalence of cardiovascular diseases and end-stage renal disease in patients with diabetes in Taiwan are still on the rise. Thus, a new approach is needed to solve these adverse health outcomes.
  • Research Priority:
  • Study outcomes should be focused on the important diabetic complications, particularly for the ones that incurred significant disease burden in Taiwan such as myocardial infarction, heart failure, and/or end-stage renal disease.
  • The applicants are encouraged to adopt a multidisciplinary approach for this research. The methodology may include (not limited to) recent developments in genetics, immunology, cell biology, biomarker profiling, therapeutic options, diagnosis tools, prediction models, epidemiological analysis, and/or artificial intelligence application.
  • The scope of this call should include at least 3 interrelated and integrated sub-projects to link a major pathway or target for the investigated outcomes.
  • Research priority of this project is to offer innovative strategies, through elucidating causal association in disease pathogenesis to developing therapeutic interventions, to prevent or reduce the targeted diabetic complications.

  • 2. 個人型計畫(IRG及CDG)

    為鼓勵創新研究並吸引優秀研究人員提出計畫申請,個人型計畫之研究重點共有10項(但不另區分子題),申請人應就研究重點深入研究國人重要疾病之成因、診斷、治療及預防,或進行醫療保健及衛生政策、制度之研究,以解決各項醫藥衛生相關問題,徵求重點如下:

    • Cancer research
    • Cardiovascular and metabolic disorders
    • Infectious diseases 
    • Mental/neurological disorders and addiction
    • Immunity and inflammation 
    • Aging
    • Biomedical engineering
    • Health policy and social welfare
    • Environmental health
    • Others

    線上申請截止期限(https://erad.nhri.org.tw/;逾時恕不受理)

    • 計畫申請書及相關附件:2019年3月29日(星期五)下午4時正
    • 申請機構公函請於2019年4月8日(星期一)下午4時正前送達本院

    申請作業手冊完整內容請點選此處下載,如有申請計畫相關疑義,請洽本院學術發展處

    • 電話:(037) 246-166疑義查詢轉33306~09、33311~13、33315~16
    • 傳真:(037) 580-762
    • e-mail: extra@nhri.org.tw
    • 網址:http://www.nhri.org.tw/pdnews【最新消息公告】

    ※由於建置個人完整資料需費時日,為節省計畫撰寫時間及避免網路壅塞,請提早申請帳號並建置個人資料

    文/圖:學術發展處

    Comments are closed.